Top

Published in:

01-04-2006 | Original Article

Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement

Authors: L. Krsková, M. Mrhalová, D. Sumerauer, R. Kodet

Published in: Virchows Archiv | Issue 4/2006

Abstract

Two histologically distinct subtypes of rhabdomyosarcomas (RMS), embryonal and alveolar, are different in many aspects, such as age distribution, primary site, and clinical outcome. We analyzed a group of 30 patients with RMS. The aim was to broaden the spectrum of diagnostic tools in evaluating the primary tumors, their recurrences and/or metastases, and to extend the diagnostic boundary to bone marrow and purged peripheral progenitor blood cell samples. We have performed the RT-PCR assay to analyze RMS for the presence of expression of MyoD1 gene and for the presence of chimeric transcripts PAX3/FKHR or PAX7/FKHR. MyoD1 gene expression was found in all 30 patients in samples from primary tumors. The chimeric transcripts PAX/FKHR were identified in 13 of 15 patients with alveolar RMS. Furthermore, the fusion transcript PAX7/FKHR was identified in 2 of 15 patients with RMS classified as embryonal by histology. Bone marrow samples (12) and peripheral blood progenitor cell specimens (13) in ten patients were examined by RT-PCR. We were able to identify 7 patients with bone marrow involvement and/or with contamination of peripheral blood progenitor cells by the tumor cells. We demonstrate that employing molecular diagnostics has an impact on staging, therapy monitoring and recognition of malignant cells at the tumor resection margins.

Afify A, Mark HF (1999) Trisomy 8 in embryonal rhabdomyosarcoma detected by fluorescence in situ hybridization. Cancer Genet Cytogenet 108:127–132CrossRefPubMed

Anderson J, Gordon A, Pritchard-Jones K, Shipley J (1999) Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 26:275–285CrossRefPubMed

Barr FG (1997) Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol 19(6):483–491CrossRefPubMed

Barr FG (1999) The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomyosarcoma. Cancer Res 59(7 Suppl):1711–1715

Bober E, Franz T, Arnold HH, Gruss P, Tremblay P (1994) PAX3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120:603–612PubMed

Cessna MH, Zhou H, Perkins SL, Tripp SR, Pickering D, Daines C, Coffin CM (2001) Are myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 25:1150–1157CrossRefPubMed

Chen B, Dias P, Jenkins JJ III, Savell VH, Parham DM (1998) Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am J Pathol 152(4):1071–1079PubMed

Coffin CM, Rulon J, Smith L, Bruggers C, White FV (1997) Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol 10:1175–1187PubMed

d’Amore ES, Tollot M, Stracca-Pansa V, Menegon A, Meli S, Carli M, Ninfo V (1994) Therapy associated differentiation in rhabdomyosarcomas. Mod Pathol 7:69–75PubMed

10.

Davis RJ, Barr FG (1997) Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A 94:8047–8051CrossRefPubMed

11.

Davis RJ, D’Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54(11):2869–2872PubMed

12.

Davis RL, Weintraub H, Lassar AB (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51(6):987–1000CrossRefPubMed

13.

Dias P, Chen B, Dilday B, Palmer H, Hosoi H, Singh S, Wu C, Li X, Thompson J, Parham D, Qualman S, Houghton P (2000) Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol 2:399–408

14.

Douglass EC, Valentine M, Etcubanas E, Paraham D, Webber BL, Houghton PJ, Houghton JA, Green AA (1987) A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45:148–155PubMedCrossRef

15.

Douglass EC, Rowe ST, Valentine M, Paraham DM, Berkow R, Bowman WP, Maurer HM (1991) Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 3(6):480–482PubMedCrossRef

16.

Douglass EC, Shapiro DN, Valentine M, Rowe ST, Carroll AJ, Raney RB, Ragab AH, Abella SM, Paraham DM (1993) Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 21:83–87PubMedCrossRef

17.

Downing JR, Khandekar A, Shurtleff SA, Head DR, Paraham DM, Webber BL, Pappo AS, Hulshof MG, Conn WP, Shapiro DN (1995) Multiplex RT-PCR assay for the differential diagnosis of alveolar and Ewing’s sarcoma. Am J Pathol 146(3):626–634PubMed

18.

Fletcher JA, Kozakewich HP, Hoffer FA (1991) Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 324:436–442PubMedCrossRef

19.

Frascella E, Toffolatti L, Rosolen A (1998) Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction. Am J Pathol 152(2):577–582PubMed

20.

Gabert J (1999) Detection of recurrent translocations using real time PCR; assessment of the technique for diagnosis and detection of minimal residual disease. Haematologica 84:107–109CrossRefPubMed

21.

Gattenloehner S, Dockhorn-Dworniczak B, Leuschner I, Vincent A, Muller-Hermelink HK, Marx A (1999) A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissue. J Mol Diagn 1(1):23–31PubMed

22.

Israeli RS, Miller WH, Su SL, Powell CT, Fair WR, Samadi SD, Huryk RF, DeBlasio A, Edwards ET, Wise GJ (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells. Comparison of prostate specific membrane antigen and prostate specific antigen-based assay. Cancer Res 54:6306–6310PubMed

23.

Kelly KM (1996) Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcription polymerase chain reaction method. Cancer 15:1320–1327CrossRef

24.

Kelly KM (1997) Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 15(5):1831–1836PubMed

25.

Kodet R (1989) Rhabdomyosarcoma in childhood. An immunohistochemical analysis with myoglobin, desmin and vimentin. Pathol Res Pract 185:207–213PubMed

26.

Kullendorff CM, Donner M, Mertens F, Mandahl N (1998) Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma. Med Pediatr Oncol 30:156–159CrossRefPubMed

27.

Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M (2000) Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol 13:988–993CrossRefPubMed

28.

Kushner BH, LaQuaglia MP, Cheung NK, Kramer K, Hamelin AC, Gerald WL, Ladanyi M (1999) Clinically critical impact of molecular genetic studies in pediatric solid tumors. Med Pediatr Oncol 33:530–535CrossRefPubMed

29.

Leuschner I, Harms D, Mattke A, Koscieniak E, Treuner J (2001) Rhabdomyosarcoma of the urinary bladder and vagina: clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 25:856–864

30.

Miettinen M, Rapola J (1989) Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Expression of cytokeratin and 68-kD neurofilament protein. Am J Surg Pathol 13:120–132PubMedCrossRef

31.

Miki H, Kobayashi S, Kushida Y, Sasaki M, Haba R, Hirakawa E, Ogura K, Ohmori M (1999) A case of infantile rhabdomyofibrosarcoma with immunohistochemical, electron microscopical, and genetic analyses. Hum Pathol 30(12):1519–1522CrossRefPubMed

32.

Mitterbauer G, Zimmer C, Pirc-Danoewinata H, Haas OA, Hojas S, Schwarzinger I, Greinix H, Jager U, Lechner K, Mannhalter C (2000) Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction. Br J Haematol 109(3):622–628CrossRefPubMed

33.

Newton WA, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, Tsokos MG, Shimada H, Harms D, Schmidt D (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification—an Intergroup Rhabdomyosarcoma Study. Cancer 75(6):1073–1085CrossRef

34.

Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlation with molecular studies. Mod Pathol 14:506–514CrossRefPubMed

35.

Parham DM, Webber B, Holt H, Williams WK, Maurer H (1991) Immunohistochemistry of childhood rhabdomyosarcomas and related neoplasms. Results of an Intergroup Rhabdomyosarcoma Study project. Cancer 67:3072–3080PubMedCrossRef

36.

Qualman SJ, Bowen J, Parham DM, Brantom PA, Meyer WH (2003) Protocol for the examination of specimens from patients (children and young adults) with rhabdomyosarcoma. Arch Pathol Lab Med 127:1290–1297PubMed

37.

Rowe D, Gerrard M, Gibbons B, Malpas JS (1987) Two further cases of t(2;13) in alveolar rhabdomyosarcoma indicating a review of the published chromosome breakpoints. Br J Cancer 56:379–380PubMed

38.

Ruymann FB, Newton WA, Ragab AH, Donaldson HM, Foulkes M (1984) Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 53:368–373PubMedCrossRef

39.

Scrable H, Witte D, Shimada H, Seemayer T, Sheng WW, Soukup S, Koufos A, Houghton P, Lampkin B, Cavenee W (1989) Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer 1(1):23–35PubMedCrossRef

40.

Stuart ET, Gruss P (1996) PAX: developmental control genes in cell growth and differentiation. Cell Growth Differ 7(3):405–412PubMed

41.

Thomson B, Hawkins D, Felgenhauer J, Radich J (1999) RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing’s sarcoma and alveolar rhabdomyosarcoma. Bone Marrow Transplant 24(5):527–533CrossRefPubMed

42.

Tobar A, Avigad S, Zoldan M, Morc C, Goshen Y, Zaizov R (2000) Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma. Diagn Mol Pathol 9(1):9–13CrossRefPubMed

43.

Tobal K, Moore H, Macheta M, Yin JA (2001) Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method. Leukemia 15(7):1060–1065CrossRefPubMed

44.

Tsokos M (1994) The diagnosis and classification of childhood rhabdomyosarcoma. Semin Diagn Pathol 11:26–38PubMed

45.

Turc-Carel C, Lizard-Nacol S, Justrabo E, Favrot M, Philip T, Tabone E (1986) Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 19:361–362CrossRefPubMed

46.

Wachtel M, Dettling M, Koscielnik E, Stegmaier S, Treuner J, Simon-Klingenstein K, Buhlmann P, Niggli FK, Schafer BW (2004) Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64(16):5539–5545CrossRefPubMed

47.

Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM (1995) Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 147(6):1799–1810PubMed

48.

Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell TK, Turner D, Rupp R, Hollenberg S (1991) The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251(4995):761–766 (Review)PubMedCrossRef

49.

Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C, von Knebel Doeberitz M (1998) Dissemination of tumor cells in patient undergoing surgery for colorectal cancer. Clin Cancer Res 4:343–348PubMed

Title: Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement
Authors: L. Krsková
M. Mrhalová
D. Sumerauer
R. Kodet
Publication date: 01-04-2006
Publisher: Springer-Verlag
Published in: Virchows Archiv / Issue 4/2006
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-005-0124-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2006

Podoplanin is expressed in subsets of tumors of the central nervous system

CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions

Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma

Expression of E-cadherin, α-catenin, and β-catenin in tubulolobular carcinoma of the breast

Melanin bearing myoepithelial cells in a pigmented salivary gland carcinoma: a new avatar of myoepithelial cell? A case report

Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy